Objective:　To　describe　the　survival　state　and　to　investigate　the　risk　factors　of　death　in　patients　with　subarachnoid　hemorrhage　(SAH).　Methods:　Age,　past　history,　number　of　cortical　regions　suffering　SAH,　laboratory　examination　parameters,　therapeutic　measures,　complications,　and　prognosis　of　174　patients　with　SAH　were　investigated.　The　survival　rates　and　risk　factors　of　death　of　the　patients　with　SAH　were　identified　by　both　Kaplan-Meier　survival　analysis　and　Cox　proportional　risk　model.　Results:　Ten　patients　were　(5.75%)　lost　to　follow-up　investigation　and　164　patients　with　SAH　completed　the　follow-up　investigation.　Sixty-six　patients　died　and　the　longest　follow-up　investigation　time　was　5.64　years.　The　survival　rates　of　28　days,　1　year,　and　3　to　5　years　were　70.60%,　63.40%,　and　57.20%,　respectively.　The　treatment　with　Nimotop,　aneurysm　surgical　occlusion,　and　aneurysm　embolotherapy　decreased　the　death　rate　of　SAH.　At　the　same　time,　advanced　age,　smoking,　hyponatremia,　rising　leukocyte　count　in　acute　stage,　repeated　hemorrhage,　and　cerebral　vasospasm　were　the　independent　risk　factors　causing　the　death　of　patients.　Conclusion:　Prognosis　of　patients　with　advanced　age,　rising　count　leukocyte　in　acute　stage,　gastrointestinal　bleeding,　hyponatremia,　repeated　hemorrhage,　and　cerebral　vasospasm　were　unfavorable.　The　death　risk　could　be　reduced　if　the　patients　with　aneurysm　received　prompt　aneurysm　occlusion　embolotherapy　and　Nimotop　treatment.